Tech-enabled healthcare services company focused on the diagnosis of epilepsy and other seizure disorders. Diagnostic testing is performed in the safety and convenience of the patients home, significantly increasing compliance and up to 10X less expensive than its hospital-based equivalent.
Recently acquired owner-operated Florida-based Company positioned for growth and expansion - last 3 years revenue with no outside sales rep (unaudited, cash basis):
2021: $270,512
2022: $396,854
2023: $439,313
Invested capital will be used to hire 2 full-time outside sales reps to fuel growth and provide working capital for medical techs required to complete diagnostic testing. Under new leadership & management, Company is capable of delivering $10M+ revenue in CY 2027. New management team has track record of success in healthcare industry, having built previous company to $70M+ annual revenue and led to successful exit.
Company has required AHCA license to perform medical services in State of Florida and is contracted with Medicare, FL Medicaid, and several commercial health plans to provide in-network diagnostic testing to patients.
Flexible on structure of investment and expect future fundraising round for continued expansion.
Investment capital = $200K for 20% equity
Full investor deck available upon request.
Ready to Ask For Funding for your company?
Post a Funding Request